• Careers

Who we are

We are an innovation-led contract research, development and manufacturing organization offering integrated scientific services from early discovery to commercial supply.

What we do

We offer clients a customized end-to-end solution to fulfil their R&D and manufacturing requirements. Our approach enables us to forge client relationships that move beyond the traditional service outsourcing model into true end-to-end collaborations.


Our Discovery Services span the entire spectrum of early stage research from target …


Our Development Services encompass activities from pre-clinical to clinical trials…


Our Manufacturing services include cGMP-compliant facilities for clinical supplies, registration batches…

Dedicated Centers

Our Dedicated Centers offer dedicated multi-disciplinary scientific teams, support…

InstaVisit - Visit Syngene Virtually

Syngene InstaVisit is an interactive virtual experience designed to give you a 360 degree view of Syngene’s world-class facilities and capabilities. The platform allows you to change your perspective, look around and zoom in as we take you on a guided tour of Syngene’s labs.

Visit Syngene virtually with a 360 degree view of Syngene’s world-class facilities and capabilities



Collaborations with the top 10 Pharma/Biotech companies

0 +

Experienced Scientists


Mn sq. ft. of R&D and manufacturing infrastructure

0 +


Syngene reports revenue from operations growth of 13% in the fourth quarter; 12% for the full year

Press Release
26th Apr, 2021

Syngene International extends long term research collaboration with Bristol Myers Squibb until 2030

Press Release
25th Apr, 2021

Inauguration of COVID-19 Vaccination Centre at Syngene International Limited, Biocon Group of Companies

Press Release
11th Apr, 2021

Complimentary techniques for determining Relative response factor of non- isolated impurities

Understanding the concept behind determining UV RRF of non-isolated impurities using High Performance Liquid Chromatography and Nuclear Magnetic Resonance

Development of degraders: A Medicinal Chemistry perspective

Key considerations for developing protein degraders from a medicinal chemistry perspective regardless of the mechanism of modulation.

Dedicated R&D Centres – The Next Step In The Pharma Outsourcing Model

Syngene’s Dedicated R&D Centre is a unique business model where we set up a dedicated ring-fenced infrastructure with an exclusive team of scientific talent to support client projects.

Upcoming events

Corporate social responsibility

To strive towards developing and sustaining healthy and empowered communities by improving the quality of life.

Syngene International Ltd



Behind consistent growth is good governance


Discover a world of opportunities

Annual Reports

Touching a billon lives through innnovation